Trial intelligence / Profile preview

BFPSCs and LRCP in Alveolar Cleft Osteoplasty

NCT02859025Phase 1Completed

Sponsor
Shahid Beheshti University of Medical Sciences
Start
Jan 2015
Primary completion
Jan 2016
Modality
Stem Cell Therapies
Countries
1
01

Overview

Phase 1, randomised, open-label trial of buccal fat pad-derived stem cells in cleft alveolus (3 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Change in bone volume at 6 months. Started Jan 2015; status: completed.

02

Drugs

buccal fat pad-derived stem cells
03

Conditions

cleft alveolus

Beyond the preview

Go deeper on NCT02859025.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02859025.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call